Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The QResearch team are pleased to share this important blog post, originally published by Blood Cancer UK, detailing the findings from a QResearch project on the effectiveness of COVID-19 vaccines for people with blood cancer. This repost highlights the collaborative efforts and crucial insights garnered by researchers, including our own Professor Julia Hippisley-Cox, in understanding vaccine efficacy for those most vulnerable during the pandemic.

Opinions expressed are those of the author/s and not of the University of Oxford. Readers' comments will be moderated - see our guidelines for further information.